-
Google PR 0Trustworthiness Unknown
-
Avg. Daily Visitors N/AChild Safety Unknown
-
Avg. Daily Pageviews N/APrivacy Unknown
You are being redirected...
Domain info
Location: | United States |
Registrant: | Domain Administration (Amgen Inc.) |
Hosted by: | Oracle Corporation |
Registrar: | MarkMonitor Inc. |
Subnetworks: | 108.59.160.10, 108.59.160.11 |
Social Media Activities
- Facebook likes: -
- Twitter mentions: -
- Google pluses: -
- LinkedIn mentions: -
- Pinterest pins: -
- StumbleUpon views: -
Web Safety
- This website is malware-free.
- Status ok
Sites associated with the same registrant
Whois
Ir.chemocentryx.com popular pages to visit
Investor FAQs - ChemoCentryx, Inc.
The Investor Relations website contains information about ChemoCentryx, Inc. business for stockholders, potential investors, and financial analysts.
News Releases - ChemoCentryx, Inc.
News Releases
Jun 16, 2016
-- Safety study objective achieved: CCX168 shown to be well tolerated in patients with ANCA-associated vasculitis when added to current standard of care regimen --
-- I...
ChemoCentryx Announces Positive Top-Line CCX168 Phase II Data in ANCA-Associated Renal Vasculitis (NASDAQ:CCXI)
.gnw_heading {font: 16px Arial; text-align: center}
.gnw_subhead {font: 12px Arial; text-align: center}
.gnw_colhead {font: 12px Arial; text-align: center}
.gnw_colhead_uline {font: 12px A...